N-TAB
Live / Registered — Registered (as of 07 Oct 2025)
What this means for you
Registered since 07 Oct 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Oct 2031: the §71 affidavit of use).
Record
- Serial number
- 79413262
- Registration number
- 7971671
- Mark type
- Word mark
- Filed
- 15 Aug 2024
- Published for opposition
- 19 Aug 2025
- Registered
- 07 Oct 2025
- Next maintenance filing
- §71 affidavit of use, due by 07 Oct 2031 (grace period to 07 Apr 2032)
- Attorney of record
- Andrew M. Smith
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, namely, drug delivery agents in the form of tablets that enable oral delivery of proteins and peptides; pharmaceutical preparations for use as peptide replacement therapy; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of metabolic conditions; pharmaceutical preparations for the treatment of short bowel syndrome; pharmaceutical preparations for the treatment of stress fractures; drug delivery agents in the form of tablets consisting of compounds that facilitate the delivery of pharmaceutical preparations
- Class 042 — Scientific and technological services: Research and development services in the field of pharmaceutical preparations; development of pharmaceutical preparations and medicines; scientific research in the medical and pharmaceutical field, and consultancy and information relating thereto; design and development of new technology for others relating to oral delivery of proteins and peptides, and consultancy and information services relating thereto; research and development in the field of drug delivery systems
- Class 045 — Legal and security services: licensing of intellectual property; licensing of technology, namely, licensing of oral drug delivery technology
Owner
- Entera Bio Ltd., IL
- Entera Bio Ltd., IL
- Entera Bio Ltd., IL
Prosecution history
- 11 Jun 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 25 May 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 25 May 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 30 Apr 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 15 Apr 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 15 Apr 2026 — FINAL DISPOSITION PROCESSED
- 07 Jan 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 07 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Aug 2025 — PUBLISHED FOR OPPOSITION
- 13 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED